Zimbabwe has declined a major American healthcare agreement valued at $367m (272 million pounds) over five years because of the United States' insistence on sensitive information.
This move came to light following a official document from December was leaked, indicating that Head of State Emmerson Mnangagwa felt the deal was "skewed".
An official spokesman has since explained that the United States was requesting genetic material for research and commercial purposes but refused to share the benefits from future medical innovations.
"We will now turn to the difficult and regrettable process of ending our health assistance in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy noted the US had donated more than $1.9bn for health programmes to Zimbabwe during the past two decades.
A medical body in Zimbabwe has appealed for continued dialogue to reach a agreement acceptable to all parties so the country's vital HIV programme can be sustained.
Broader Implications
This development comes after a comparable situation in neighbouring Kenya, where a court blocked a related health funding agreement following concerns were raised about the security of Kenyans' health data.
After returning to the presidency last year, US President Donald Trump has slashed foreign aid and closed the key foreign aid agency.
USAID had overseen assistance for the American government, but Trump claimed its spending was "wasteful" and his government was seeking direct bilateral deals to enhance openness and responsibility.
As per reports, 16 nations in Africa have to date signed these new health pacts, constituting more than $18.3bn in new funding.
Specifics of the Declined Deal
The funds for Zimbabwe would have funded "HIV/Aids treatment and prevention, tuberculosis, malaria, maternal and child health, and preparing for epidemics".
"We believe this collaboration might have yielded significant advantages for the people of Zimbabwe, particularly the 1.2 million men, women and children presently receiving HIV treatment via US-supported programmes," Tremont added.
However, government spokesperson Nick Mangwana argued the arrangement was "unfair".
"The proposal required Zimbabwe to provide its biological resources and data indefinitely, with no corresponding promise of access to any medical innovations – such as new medicines or tests – that might be developed from that shared data," he stated.
"In essence, our nation would supply the basic resources for scientific discovery with no assurance that the resulting innovations would be accessible to our people if a future health crisis arise."
Sovereignty and International Frameworks
He also noted that the US's withdrawal from the global health body and its pursuit of bilateral deals were upending systems already established through the international health agency.
Mangwana gave as an example its Pathogen Access and Benefit Sharing scheme designed to manage potential pandemics.
"This system is intended to ensure that when a country provides its samples, the benefits – including medicines and cures – are distributed fairly, not monopolised exclusively by those with the resources to develop them."
Zimbabwe's reservations regarding the US deal "should not be misconstrued as hostility towards the US," he added.
"We are open to further discussions with our US partners on how subsequent collaboration might be designed in a manner that honours the sovereignty and dignity of both nations."
Health Experts Reaction
A leading public health body expressed it understood the official position, but suggested that talks must proceed given that much of the country's HIV programmes were funded by foreign aid.
"Where technical issues arise, including those involving information security or agreement terms, these can frequently be addressed via detailed discussion and mutually agreed protections," the group added.
This impasse underscores the complex debate between accepting much-needed international aid and protecting local interests in an ever more interconnected world.